Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Changes in hippocampal metabolites after effective treatment for fibromyalgia: a case study.

Wood PB, Ledbetter CR, Patterson JC 2nd.

Clin J Pain. 2009 Nov-Dec;25(9):810-4. doi: 10.1097/AJP.0b013e3181af129e.

PMID:
19851163
2.

Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features.

Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd.

J Pain. 2009 Jan;10(1):47-52. doi: 10.1016/j.jpain.2008.07.003. Epub 2008 Sep 4.

PMID:
18771960
3.

Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity.

Petrou M, Harris RE, Foerster BR, McLean SA, Sen A, Clauw DJ, Sundgren PC.

AJNR Am J Neuroradiol. 2008 May;29(5):913-8. doi: 10.3174/ajnr.A0959. Epub 2008 Mar 13.

4.

Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy.

Li LM, Cendes F, Antel SB, Andermann F, Serles W, Dubeau F, Olivier A, Arnold DL.

Ann Neurol. 2000 Feb;47(2):195-200.

PMID:
10665490
5.

Reduced N-acetylaspartate in the hippocampus in patients with fibromyalgia: a meta-analysis.

Aoki Y, Inokuchi R, Suwa H.

Psychiatry Res. 2013 Sep 30;213(3):242-8. doi: 10.1016/j.pscychresns.2013.03.008. Epub 2013 Jul 5.

PMID:
23835064
6.

Hippocampal 1H MRS in first-episode bipolar I patients.

Atmaca M, Yildirim H, Ozdemir H, Poyraz AK, Tezcan E, Ogur E.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1235-9. Epub 2006 May 24.

PMID:
16725248
7.
8.

Single voxel proton magnetic resonance spectroscopy in post-stroke depression.

Glodzik-Sobanska L, Slowik A, McHugh P, Sobiecka B, Kozub J, Rich KE, Urbanik A, Szczudlik A.

Psychiatry Res. 2006 Dec 1;148(2-3):111-20. Epub 2006 Nov 7.

PMID:
17088051
9.

Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.

Vagnozzi R, Signoretti S, Tavazzi B, Floris R, Ludovici A, Marziali S, Tarascio G, Amorini AM, Di Pietro V, Delfini R, Lazzarino G.

Neurosurgery. 2008 Jun;62(6):1286-95; discussion 1295-6. doi: 10.1227/01.neu.0000333300.34189.74.

PMID:
18824995
10.

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.

Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR.

Biol Psychiatry. 2003 May 15;53(10):906-13.

PMID:
12742678
11.
12.

Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging.

Hsu YY, Chang C, Chang CN, Chu NS, Lim KE, Hsu JC.

AJNR Am J Neuroradiol. 1999 Apr;20(4):643-51.

13.

Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome. A study with single-voxel magnetic resonance spectroscopy.

Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ.

J Rheumatol. 2008 Jul;35(7):1371-7. Epub 2008 May 15.

PMID:
18484688
14.

Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy.

Martin RC, Sawrie S, Hugg J, Gilliam F, Faught E, Kuzniecky R.

Neurology. 1999 Dec 10;53(9):2052-8.

PMID:
10599780
15.

Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.

Pohl C, Block W, Karitzky J, Träber F, Schmidt S, Grothe C, Lamerichs R, Schild H, Klockgether T.

Arch Neurol. 2001 May;58(5):729-35.

PMID:
11346367
16.

White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?

Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J.

Acad Radiol. 2006 Feb;13(2):229-35.

PMID:
16428059
17.

Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.

Appenzeller S, Li LM, Costallat LT, Cendes F.

Brain. 2005 Dec;128(Pt 12):2933-40. Epub 2005 Sep 29.

PMID:
16195241
18.

High field (1)H MRS of the hippocampus after donepezil treatment in Alzheimer disease.

Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Apr 1;32(3):786-93. doi: 10.1016/j.pnpbp.2007.12.011. Epub 2007 Dec 23.

PMID:
18252268
19.

Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy.

Baik HM, Choe BY, Son BC, Jeun SS, Kim MC, Lee KS, Kim BS, Lee JM, Lee HK, Suh TS.

Eur J Radiol. 2003 Sep;47(3):179-87.

PMID:
12927660
20.

Reproducibility of proton magnetic resonance spectroscopy imaging measurements of normal human hippocampus at 1.5 T: clinical implications.

Maton B, Londono A, Sawrie S, Knowlton R, denHollander J, Kuzniecky R.

J Neuroimaging. 2001 Apr;11(2):194-201.

PMID:
11296592

Supplemental Content

Support Center